Vaccine major Serum Institute of India said it plans to start production of the COVID-19 vaccine developed by Oxford University in the next two to three weeks and hopes to bring it to the market by October if human clinical trials are successful.
The Pune-based company has partnered with Oxford University as one of the seven global institutions manufacturing the vaccine.
“Our team has been working closely with Dr Hill from Oxford University and we are expecting to initiate production of the vaccine in 2-3 weeks and produce 5 million doses per month for the first 6 months, following which we hope to scale up production to 10 million doses per month,” said Serum Institute CEO Adar Poonawalla.
